Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease
- 9 November 2022
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 38 (2) , 185-195
Abstract
Neuromelanin‐containing dopaminergic neurons in the substantia nigra pars compacta (SNpc) are the most vulnerable neurons in Parkinson's disease (PD). Recent work suggests that the accumulation of oxidized dopamine and neuromelanin mediate the convergence of mitochondrial and lysosomal dysfunction in patient‐derived neurons. In addition, the expression of human tyrosinase in mouse SNpc led to the formation of neuromelanin resulting in the degeneration of nigral dopaminergic neurons, further highlighting the importance of neuromelanin in PD. The potential role of neuromelanin in PD pathogenesis has been supported by epidemiological observations, whereby individuals with lighter pigmentation or cutaneous malignant melanoma exhibit higher incidence of PD. Because neuromelanin and melanin share many functional characteristics and overlapping biosynthetic pathways, it has been postulated that genes involved in skin pigmentation and melanin formation may play a role in the susceptibility of vulnerable midbrain dopaminergic neurons to neurodegeneration. Here, we highlight potential mechanisms that may explain the link between skin pigmentation and PD, focusing on the role of skin pigmentation genes in the pathogenesis of PD. We also discuss the importance of genetic ancestry in assessing the contribution of pigmentation‐related genes to risk of PD. © 2022 International Parkinson and Movement Disorder Society.Keywords
Funding Information
- National Institutes of Health (1R21AG064470‐01)
This publication has 113 references indexed in Scilit:
- Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL studyPigment Cell & Melanoma Research, 2012
- TPC2 Is a Novel NAADP-sensitive Ca2+ Release Channel, Operating as a Dual Sensor of Luminal pH and Ca2+Journal of Biological Chemistry, 2010
- LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseMovement Disorders, 2010
- Human skin pigmentation as an adaptation to UV radiationProceedings of the National Academy of Sciences, 2010
- Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome‐specific and proteolytically released proteinThe FASEB Journal, 2010
- Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s DiseaseNeurotoxicity Research, 2009
- Genetic risk factors for melanomaHuman Genetics, 2009
- Genetic determinants of hair color and parkinson's disease riskAnnals of Neurology, 2009
- The Protective Role of Melanin Against UV Damage in Human Skin†Photochemistry and Photobiology, 2007
- The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surfaceProceedings of the National Academy of Sciences, 2006